Hematologia Geral
Revisão JACC | Anticoagulação em pacientes com COVID-19.
2 Mar, 2022 | 11:42hComentário: Review of Anticoagulation in Patients With COVID-19: Key Points – American College of Cardiology
Dois amplos estudos de base populacional mostram um risco ligeiramente aumentado de eventos trombóticos após vacinação contra COVID-19 com a vacina da AstraZeneca.
24 Fev, 2022 | 15:47hComentários:
Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax – TCTMD
Revisão | Tromboembolismo venoso associado a câncer.
22 Fev, 2022 | 14:37hCancer-associated venous thromboembolism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)
Infográfico: Cancer-associated venous thromboembolism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)
Conteúdos relacionados:
NCCN Guideline: Cancer-Associated Venous Thromboembolic Disease.
ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer
Review: venous and arterial thromboembolism in patients with cancer.
Estudo prospectivo de diagnóstico e tratamento | Diagnóstico de trombose venosa profunda com D-dímero ajustado para probabilidade clínica.
17 Fev, 2022 | 14:23hUma ampla coorte de pacientes com síndrome nefrótica mostrou que o risco de tromboembolismo arterial (HR = 3,11), tromboembolismo venoso (HR = 7,11) e sangramento (HR = 4,02) foi bastante aumentado após ajuste dos elementos confundidores.
15 Fev, 2022 | 11:27hRisk of arterial thromboembolism, venous thromboembolism, and bleeding in patients with nephrotic syndrome: A population-based cohort study – American Journal of Medicine (link para o resumo – $ para o texto completo)
Revisão | Tratamento do tromboembolismo venoso na gestação.
14 Fev, 2022 | 15:44hManagement of venous thromboembolism in pregnancy – Thrombosis Research
Conteúdos relacionados:
Management of high-risk pulmonary embolism in pregnancy.
Study: Diagnosis of Pulmonary Embolism During Pregnancy
Imaging is the only way to diagnose blood clots in pregnancy
Terapia genética com betibeglogene autotemcel para betatalassemia não-beta-0/beta-0.
14 Fev, 2022 | 15:39hBetibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
Visual Abstract: Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia. https://t.co/2GOCGxrruv pic.twitter.com/zLvuuuByXN
— NEJM (@NEJM) February 8, 2022
Diretriz atualizada da IDSA para Covid-19 agora apoia o uso de plasma convalescente em pacientes ambulatoriais com COVID-19 leve a moderada sob alto risco de progressão para doença grave.
10 Fev, 2022 | 13:18hConteúdo relacionado: [Preprint] RCT: In symptomatic adults above 18 years positive for SARS-CoV-2, early outpatient treatment with high-titer convalescent plasma significantly reduced hospitalizations.
Comentário no Twitter
Update Alert: Revised recommendation on the use of #convalescentplasma in ambulatory patients w/ COVID-19 at high risk of progression to severe disease w/ no other treatment options.
📄: https://t.co/YRCxtdilXT#COVID19Guidelines @JGPharmD @adarsh_bhimraj @RMKGandhi @ShohamTxID pic.twitter.com/KpXnywH362
— IDSA (@IDSAInfo) February 8, 2022